Atlas Trials

A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

Clinical trial NCT01345045 · COMPLETED

Trial details

NCT number
NCT01345045
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathic Pain
Start date
2011-04-01
Primary completion
2011-10-01
Enrollment
193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.